1. Home
  2. CMPS vs TLS Comparison

CMPS vs TLS Comparison

Compare CMPS & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • TLS
  • Stock Information
  • Founded
  • CMPS 2020
  • TLS 1969
  • Country
  • CMPS United Kingdom
  • TLS United States
  • Employees
  • CMPS N/A
  • TLS N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • TLS EDP Services
  • Sector
  • CMPS Health Care
  • TLS Technology
  • Exchange
  • CMPS Nasdaq
  • TLS Nasdaq
  • Market Cap
  • CMPS 362.6M
  • TLS 306.7M
  • IPO Year
  • CMPS 2020
  • TLS 2020
  • Fundamental
  • Price
  • CMPS $5.04
  • TLS $3.30
  • Analyst Decision
  • CMPS Strong Buy
  • TLS Buy
  • Analyst Count
  • CMPS 7
  • TLS 6
  • Target Price
  • CMPS $30.67
  • TLS $4.80
  • AVG Volume (30 Days)
  • CMPS 1.5M
  • TLS 666.8K
  • Earning Date
  • CMPS 10-31-2024
  • TLS 11-12-2024
  • Dividend Yield
  • CMPS N/A
  • TLS N/A
  • EPS Growth
  • CMPS N/A
  • TLS N/A
  • EPS
  • CMPS N/A
  • TLS N/A
  • Revenue
  • CMPS N/A
  • TLS $122,959,000.00
  • Revenue This Year
  • CMPS N/A
  • TLS N/A
  • Revenue Next Year
  • CMPS N/A
  • TLS $43.60
  • P/E Ratio
  • CMPS N/A
  • TLS N/A
  • Revenue Growth
  • CMPS N/A
  • TLS N/A
  • 52 Week Low
  • CMPS $4.05
  • TLS $1.89
  • 52 Week High
  • CMPS $12.75
  • TLS $5.03
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 39.50
  • TLS 38.94
  • Support Level
  • CMPS $4.79
  • TLS $3.65
  • Resistance Level
  • CMPS $5.57
  • TLS $4.82
  • Average True Range (ATR)
  • CMPS 0.47
  • TLS 0.30
  • MACD
  • CMPS -0.00
  • TLS -0.08
  • Stochastic Oscillator
  • CMPS 40.74
  • TLS 3.18

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: